Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.36%1.28B | 6.10%873.04M | 17.11%4.19B | 24.52%1.12B | 25.02%1.05B | 10.47%822.87M | 30.48%3.57B | 45.52%1.09B | 45.68%896.99M | 18.63%843.76M |
| Cost of revenue | 7.60%1.09B | 5.80%786.08M | 14.11%3.79B | 20.87%1.02B | 19.09%937.06M | 3.77%742.96M | 24.44%3.32B | 30.17%981.4M | 40.75%840.38M | 18.64%786.82M |
| Gross profit | 82.29%184.45M | 8.82%86.95M | 56.89%392.81M | 78.74%101.19M | 106.93%117.82M | 176.02%79.9M | 266.81%250.38M | 2,096.37%107.88M | 204.05%56.61M | 18.45%56.94M |
| Operating expense | 15.06%69.03M | 22.86%57.88M | 20.31%223.92M | 16.20%59.99M | 28.23%45.94M | 11.15%47.11M | 55.39%186.12M | 175.66%56.28M | 48.21%51.63M | 78.51%35.82M |
| Selling and administrative expenses | 19.45%68.64M | 22.42%57.94M | 18.78%223.94M | 11.40%57.46M | 27.90%45.79M | 11.39%47.33M | 23.15%188.54M | 44.32%58.67M | 35.06%51.58M | 18.99%35.8M |
| -General and administrative expense | 19.45%68.64M | 22.42%57.94M | 18.78%223.94M | 11.40%57.46M | 27.90%45.79M | 11.39%47.33M | 23.15%188.54M | 44.32%58.67M | 35.06%51.58M | 18.99%35.8M |
| Other operating expenses | -83.52%417K | 28.57%18K | 482.98%548K | 2,651.09%2.53M | 539.39%211K | -88.98%14K | 64.91%94K | -609.68%-158K | 9,100.00%92K | --33K |
| Total other operating income | --26K | -65.38%81K | -77.08%576K | ---- | 662.50%61K | -0.43%234K | -92.47%2.51M | -89.01%2.23M | -98.78%41K | -99.92%8K |
| Operating profit | 180.21%115.42M | -11.34%29.08M | 162.83%168.9M | 727.15%41.19M | 240.47%71.88M | 344.16%32.8M | 224.74%64.26M | 299.83%51.6M | 130.71%4.98M | -24.60%21.11M |
| Net non-operating interest income (expenses) | 3,119.82%13.41M | -160.71%-3.23M | -168.68%-14.93M | -207.51%-444K | -284.15%-10.21M | 17,241.94%5.31M | 206.03%21.73M | 254.62%15.8M | -89.33%413K | 184.75%5.55M |
| Non-operating interest income | 69.15%26.83M | 9.09%19.42M | -24.86%68.25M | 9.31%15.86M | 1.44%17.09M | 48.70%17.8M | 41.07%90.83M | 232.53%47.5M | 12.61%14.51M | -19.60%16.85M |
| Non-operating interest expense | -17.69%13.42M | 81.33%22.65M | 20.36%83.17M | 15.66%16.31M | 141.55%27.3M | 4.05%12.49M | -18.59%69.1M | 29.36%31.7M | 56.38%14.1M | -58.90%11.3M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -35.90%17.67M | 4.81%46.13M | 19.68%154M | -18.90%27.56M | 401.09%38.03M | 29.06%44.01M | 1.44%128.68M | -11.57%53M | 84.20%33.99M | -67.99%7.59M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 114.46%146.5M | -12.35%71.98M | 43.47%307.98M | 73.47%68.31M | 191.12%99.7M | 297.97%82.12M | 291.48%214.67M | 403.88%120.41M | 545.13%39.38M | -24.17%34.25M |
| Income tax | 130.12%27.17M | -19.28%8.82M | -49.65%44.67M | -43.71%11.81M | 247.81%21.93M | -2.68%10.93M | 547.96%88.71M | 1,130.76%50.2M | 134.66%20.98M | -52.47%6.3M |
| Net income | 111.19%119.33M | -11.29%63.15M | 109.05%263.31M | 207.03%56.5M | 178.33%77.77M | 657.13%71.19M | 206.14%125.96M | 144.07%70.21M | 749.14%18.4M | -12.41%27.94M |
| Net income continuous operations | 111.19%119.33M | -11.29%63.15M | 109.05%263.31M | 207.03%56.5M | 178.33%77.77M | 657.14%71.19M | 206.13%125.96M | 144.07%70.21M | 749.14%18.4M | -12.41%27.94M |
| Noncontrolling interests | 98.57%18.88M | -13.12%7.52M | 45.82%42.9M | 51.10%9.51M | 124.82%16.29M | 37.19%8.65M | 681.17%29.42M | 117.93%9.58M | 1,001.58%6.29M | 7,072.28%7.24M |
| Net income attributable to the company | 113.75%100.45M | -11.03%55.64M | 128.31%220.41M | 288.05%46.99M | 197.06%61.48M | 1,919.21%62.54M | 158.28%96.54M | 148.79%60.63M | 666.68%12.11M | -34.92%20.7M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 1K | 1K | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 113.74%100.45M | -11.03%55.64M | 128.31%220.4M | 288.05%46.99M | 197.06%61.48M | 1,919.86%62.54M | 158.28%96.54M | 148.79%60.63M | 666.95%12.11M | -34.92%20.7M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 113.04%1.47 | -11.96%0.81 | 108.39%3.23 | 283.33%0.69 | 143.24%0.9 | 1,740.00%0.92 | 134.85%1.55 | 123.26%0.96 | 550.00%0.18 | -33.93%0.37 |
| Diluted earnings per share | 113.04%1.47 | -11.96%0.81 | 108.39%3.23 | 283.33%0.69 | 143.24%0.9 | 1,740.00%0.92 | 134.85%1.55 | 123.26%0.96 | 550.00%0.18 | -33.93%0.37 |
| Dividend per share | 0 | 0 | 255.99%0.5048 | 0 | 0.1864 | 0 | 0.1418 | 0.1418 | 0 | 0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |